QuantiFERON-TB Gold Plus is the world’s leading IGRA blood test, with millions of tests performed annually. It is established as a superior alternative to the dated TB skin test (TST), which is ...

QIAGEN, a leading provider of innovative diagnostic solutions, plays a pivotal role in these efforts through its groundbreaking product, the QuantiFERON-TB Gold Plus test (QFT-Plus).

IGRAs, such as the QuantiFERON-TB Gold test and the T-SPOT.TB test, measure the release of interferon-gamma by T-cells in response to TB antigens. Unlike TST, IGRAs are not affected by prior BCG ...

Tunisian Society of Nephrology first professional body in the field to publish nationwide guidanceAssociation of specialists recommends national immune response monitoring for cytomegalovirus (CMV) ...

First-of-its-kind systematic review on the clinical relevance of test values from the QuantiFERON-TB Gold Plus TB1 and TB2 blood collection tubes has been published // Study including 4,050 ...

QuantiFERON-TB Gold Plus is the world’s leading IGRA blood test, with millions of tests performed annually. It has established itself as a superior alternative to the dated TB skin test (TST), which ...

VENLO, The Netherlands-- (BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading ...

Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class C Certification marks milestone in QIAGEN's transition to full compliance with new EU regulations ...

VENLO, The Netherlands– (BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading tuberculosis (TB) blood test – under ...